
Zvoľte si etiketu
zobrazené priamo na liekovkeLaboratórna správa
PDF- Testované
- Thymosin Alpha-1 5mg
- Laboratórium
- Analiza Białek
- Dátum
- November 2026
- Výsledok
- 99% purity (5.33 mg measured)
- Endotoxíny
- 4.56 EU/vial
- Č. objednávky
- Heslo
Testované nezávisle, overiteľné heslom priamo v laboratóriu.
Thymosin Alpha-1
Immune System
- Laboratórne testované · Čistota 99 %
- Odosielame z Nemecka
Objednávka
- DHL so sledovaním zásielky
- Diskrétne balenie
V skratke
Thymosin Alpha-1 v číslach
Kľúčové údaje z nášho lexikónu.
Celé heslo v lexikóne- Class
- Immune-modulating peptidethymus-derived
- Frequency
- ~2x per weekin phases
- Form
- Lyophilised powderreconstituted with BAC water
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
The source in the lexiconRandomized controlled study of thymosin alpha-1 in severe sepsis (ETASS) (opens in a new tab)
Wu et al., Critical Care, 2013
Hodnotenia
Čo hovoria zákazníci
Len skutočné objednávky, ktoré obsahovali Thymosin Alpha-1.
Všetky hodnoteniaZnalosti
Všetko o Thymosin Alpha-1
Podrobné informácie pripravujeme.
Dávkovanie
Načítavajú sa informácie o dávkovaní …
Hodí sa priobjednať
Čo k tomu potrebujete
Bakteriostatická voda sa do košíka pridá automaticky. Striekačky a tampóny jedným kliknutím.
Inzulínové striekačky
10 ks · 5.50 €
Alkoholové tampóny
50 ks · 10 €
Koľko vody?
Jednotky na striekačke pre vašu veľkosť liekovky.
Otvoriť kalkulačku →Is Thymosin Alpha-1 approved?
Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.
How does Thymosin Alpha-1 work?
In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.
What do the sepsis trials show?
In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.
Are there data on cancer?
In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.
Does it help in severe pancreatitis?
Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.
Which side effects are known?
In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.
Súvisiace
Súvisiace produkty
Thymalin
Peptidy · Imunitný systém Imunitný systém
2 veľkosti
= od 16 €/liekovka
KPV
Peptidy · Imunitný systém Imunitný systém
4 veľkosti
Laboratórne testované
= od 11.6 €/liekovka
VIP
Peptidy · Imunitný systém Imunitný systém
2 veľkosti
= od 23.2 €/liekovka
VIP Nasal
Peptidy · Imunitný systém Imunitný systém
1 veľkosť
Thymosin Alpha-1